[Webinar] Targeting DNA Damage Repair for Drug Discovery Using the Transcreener ADPR® Assay
Thursday, 04 May 2023
Interested in DNA damage repair pathways for drug discovery? Join us for a live webinar, where Ha Pham, senior scientist at BellBrook Labs, will be sharing her expertise on using the Transcreener ADPR Assay, a biochemical HTS assay, to study enzymes involved in DNA damage repair. She will use CD38 and PARG as target examples
- Published in Emerging Targets, HTS Assays, Innate Immunity
No Comments
The Challenging Search for BTK Inhibitors
Tuesday, 27 December 2022
Bruton’s Tyrosine Kinase (BTK) is a 76kDa non-receptor Tec kinase that plays numerous diverse roles in B-cell development, immunity, autoimmunity, infection, and cancer. From stem to stern, it consists of an N-terminal plekstrin homology (PH) domain, a TEC homology (TH) domain, two SRC homology (SH2 and SH3) domains, and a C-terminal kinase domain. Unlike SRC,
- Published in Emerging Targets, HTS Assays, Innate Immunity
SIRT2 Isoforms in Neurodegenerative Diseases & Cancer
Tuesday, 29 November 2022
Silent information regulator type 2 (Sirtuin 2 or SIRT2) is a highly evolutionarily conserved NAD+ dependent deacetylase. SIRT2 is the only Sirtuin that acts in the cytosol. It expresses in almost all tissues, but most abundantly in the central nervous system. While SIRT2 is classified as a type III histone deacetylase, it is also capable
- Published in Emerging Targets, HTS Assays, Innate Immunity, Neurodegenerative Diseases
Can WRN Helicase Inhibitors Treat MSI-H Cancers?
Tuesday, 04 October 2022
Over 100 years ago, Otto Werner first characterized a recessive autosomal disorder that caused premature, but largely typical, aging in adults, starting by the 3rd decade and resulting in death by the 6th decade via myocardial infarction or cancer. This disease, now known as Werner syndrome, is caused by specific alterations in the 162 KDa
- Published in Emerging Targets, HTS Assays, Innate Immunity
NSP16 Shows Promise for Anti-Viral Therapeutics
Tuesday, 20 September 2022
SARS-CoV-2 virus (Covid-19) possesses one of the largest genomes of any RNA virus. While it naturally encodes structural proteins among its 29 genes, it also produces non-structural proteins that are necessary to perpetuate infection. Non-structural protein 16 (NSP16) is one such protein.1 NSP16 Camouflages Viral mRNA NSP16 is an m7GpppA-specific, S-adenosyl-L-methionine-dependent 2’-O-methyltransferase (2’-O-MTase) that “caps”
- Published in Emerging Targets, HTS Assays, Innate Immunity
Looking Ahead: POLQ in the Future of Immuno-Oncology
Tuesday, 06 September 2022
The most well-known and widely studied mechanisms of double-stranded DNA break (DSB) repairs are homologous recombination (HR) and classical non-homologous end joining (C-NHEJ). HR is almost error-free due to formatting by the homologous sister chromosome. C-NHEJ relies on direct ligation of double-stranded DNA ends and only ever presents errors at the junction points. Recently, a
- Published in Emerging Targets, HTS Assays, Innate Immunity
Discovering the Emerging Importance of PARG in Immunity
Monday, 08 August 2022
Poly (ADP-ribose) glycohydrolase (PARG), along with poly (ADP-ribose) polymerase 1 (PARP1) are the principal elements of the DNA damage response (DDR). When single-strand breaks occur in cellular DNA, PARP1 mediates the poly ADP ribosylation of itself and target proteins, such as histones, promoting the decompaction of chromatin and recruiting relevant enzymes to initiate DNA repair.
- Published in Emerging Targets, HTS Assays, Innate Immunity
Helicases as Powerful Tools in Innate Immunity
Monday, 11 July 2022
Helicases are among the largest and most highly conserved families of enzymatic proteins in eukaryotic organisms. These proteins utilize NTP hydrolysis (usually ATP) to drive their recognition, remodeling, and response to target DNA or RNA.1 Nearly every aspect of nucleic acid metabolism is mediated by helicases. DNA helicases function in replication, repair, recombination, transcription, chromosome
- Published in Emerging Targets, HTS Assays, Innate Immunity
OAS1: The Cost of Host Defense
Monday, 13 June 2022
OAS1 (Oligoadenylate synthetase 1) is induced by type 1 interferon signaling. It recognizes 18 bp (or longer) double stranded RNA segments from invading viruses in the cytosol and catalyzes the production of 2’-5’ linked oligoadenylate (2-5A) from ATP. The 2-5A then, at the expense of yet more ATP, exclusively activates endoribonclease L (RNase L) by
- Published in Emerging Targets, HTS Assays, Innate Immunity, Products